This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Polycystic Ovary Syndrome or Endothelial Dysfunction
and you are
between 15 and 35
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to assess the effects of ethinylestradiol 30µg-drospirenone combined with metformin and weight loss by means of dietary intervention on the indices of endothelial dysfunction (i.e. flow-mediated dilation and serum endothelin-1), serum hsCRP,lipids,insulin resistance and body composition in young women with PCOS.

Provided treatments

  • Drug: Metformin, Ethinylestradiol 30µg-Drospirenone

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01459445. The sponsor of the trial is Iuliu Hatieganu University of Medicine and Pharmacy and it is looking for 26 volunteers for the current phase.
Official trial title:
Metformin Plus EE30µg-drospirenone and Weight Loss- Impact on Endothelial Function and hsCRP Levels in PCOS